ESMO Gastrointestinal Oncology

Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination

Pub Date : 2025-02-20 DOI: 10.1016/j.esmogo.2025.100143 Y. Suzuki , K. Shimozaki , S. Udagawa , K. Chin , H. Osumi , S. Fukuoka , K. Yoshino , M. Tamba , T. Wakatsuki , M. Ogura , E. Shinozaki , K. Yamaguchi , A. Ooki

Systemic management of advanced HCC: an increasingly complex game

Pub Date : 2025-02-17 DOI: 10.1016/j.esmogo.2025.100139 A. Martirena , P. Lombardi , D.J. Pinato , L. Rimassa , A. Lamarca

Re-evaluating population-level screening recommendations to address increasing early-onset colorectal cancer rates in Australia: a modelling study☆

Pub Date : 2025-02-17 DOI: 10.1016/j.esmogo.2025.100136 J.-B. Lew , J. Worthington , H. Ge , Q. Luo , E. Feletto , K. Canfell , T. Price , Cancer Council Australia Colorectal Cancer Screening Working Party